Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

Summary

ASCAPE (Artificial intelligence Supporting CAncer Patients across Europe) is a collaborative research project involving 15 partners from 7 countries, including academic medical centers, SMEs (small and medium-sized enterprises), research centers and universities, aiming to leverage the recent advances in Big Data and AI (Artificial Intelligence) to support cancer patients' Quality of Life (QoL) and health status. Specifically, ASCAPE aims to provide personalized- and AI-based predictions for QoL issues in breast- and prostate cancer patients as well as suggest potential interventions to their physicians.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 875351.

Conditions

• Breast Cancer
• Prostate Cancer
• Quality of Life
• Survivorship
• Toxicity

Interventions

OTHER

ASCAPE-based follow-up strategy

Follow-up through ASCAPE platform including AI-based predictions for health-related QoL issues and suggestions for personalized interventions depending on the type of QoL issue that needs to be tackled. The ASCAPE-based follow-up strategy includes follow-up through validated QoL questionnaires, wearables for capturing active monitoring data, and mobile apps for answering the questionnaires and capturing potential health-related issues.

Sponsors & Collaborators

• UBITECH

  collaborator UNKNOWN

• ATOS

  collaborator UNKNOWN

• Siemens Corporation, Corporate Technology

  collaborator INDUSTRY

• Intrasoft

  collaborator UNKNOWN

• University of Patras

  collaborator OTHER

• FORTH - Foundation for Research and Technology Hellas

  collaborator UNKNOWN

• Sphynx Technology Solutions AG

  collaborator UNKNOWN

• Faculty of Sciences, University of Novi Sad, Serbia

  collaborator UNKNOWN

• DFKI - German Research Center for Artificial Intelligence

  collaborator UNKNOWN

• CareAcross

  collaborator INDUSTRY

• National and Kapodistrian University of Athens, Greece

  collaborator UNKNOWN

• Fundacio Clinic Barcelona

  collaborator OTHER

• Arthur's Legal

  collaborator UNKNOWN

• Fundacion iSYS

  collaborator UNKNOWN

• Region Örebro County

  lead OTHER

Principal Investigators

• Paris Kosmidis · CareAcross

• Serge Autexier · German Research Center for Artificial Intelligence

Study Design

Allocation

NA

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-02-01

Primary Completion

2024-06-30

Completion

2025-08-30

Countries

• Greece
• Spain
• Sweden
• United Kingdom

Study Locations